Ganglioside control over IL-4 priming and cytokine production in activated T cells

被引:29
作者
Chen, XP
Ding, XH
Daynes, RA
机构
[1] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA
[2] Educ & Clin Ctr, Salt Lake City, UT USA
[3] Salt Lake City Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Salt Lake City, UT USA
关键词
cellular differentiation; cytokines; gene regulation; immunomodulators; Th-1; Th-2;
D O I
10.1006/cyto.1999.0596
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our previous studies have shown that the enzymatic activities of Neu-1, an endogenous sialidase encoded in the murine MHC, are involved in promoting IL-4 synthesis by naive CD4(+) T cells, Our present studies have characterized responsible sialoconjugate targets of Neu-1 and questioned possible biochemical mechanisms responsible for their regulatory influences on IL-4 gene expression, These studies determined that treatment of T cells with the naturally occurring ganglioside GM3 inhibited the production of IL-4 without affecting the production of IL-2, An analysis of IL-4-primed CD4(+) T cells further demonstrated that GM3 treatment specifically inhibited the restimulated production of IL-4, IL-5 and IL-13, without inhibiting the production of IL-2 and IFN-gamma. The inhibitory effects of GM3 could be overcome by treatment with thapsigargin or ionomycin, suggesting ganglioside regulation occurs upstream of activation-induced calcium mobilization GM3 treatment attenuated the level of calcium influx following CD3 epsilon crosslinking, and CD4(+) T cells from Neu-1-deficient B10.SM strain mice (neur-1(alpha) and IL-4-deficient) expressed reduced levels of intracellular calcium following activation, Our results indicate that activities by membrane gangliosides can influence the cytokine programs in CD4(+) T cells, possibly through the modulation of calcium responses induced by T cell activation. (C) 2000 Academic Press.
引用
收藏
页码:972 / 985
页数:14
相关论文
共 51 条
[1]   T(H)2 AND T(H)2-LIKE CELLS IN ALLERGY AND ASTHMA - PHARMACOLOGICAL PERSPECTIVES [J].
ANDERSON, GP ;
COYLE, AJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (09) :324-332
[2]  
Anderson R G, 1994, Semin Immunol, V6, P89, DOI 10.1006/smim.1994.1013
[3]  
Chen XP, 1997, J IMMUNOL, V158, P3070
[4]  
CHU JWK, 1995, IMMUNOLOGY, V84, P396
[5]   PLATELET-DERIVED GROWTH-FACTOR IS A POTENT BIOLOGIC RESPONSE MODIFIER OF T-CELLS [J].
DAYNES, RA ;
DOWELL, T ;
ARANEO, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1323-1333
[6]   Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis [J].
DeMaria, R ;
Lenti, L ;
Malisan, F ;
dAgostino, F ;
Tomassini, B ;
Zeuner, A ;
Rippo, MR ;
Testi, R .
SCIENCE, 1997, 277 (5332) :1652-1655
[7]   SWITCH OF CD8 T-CELLS TO NONCYTOLYTIC CD8-CD4- CELLS THAT MAKE T(H)2 CYTOKINES AND HELP B-CELLS [J].
ERARD, F ;
WILD, MT ;
GARCIASANZ, JA ;
LEGROS, G .
SCIENCE, 1993, 260 (5115) :1802-1805
[8]  
FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29
[9]   STRUCTURE AND FUNCTION OF SPHINGOGLYCOLIPIDS IN TRANSMEMBRANE SIGNALING AND CELL-CELL INTERACTIONS [J].
HAKOMORI, S .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (03) :583-595
[10]   CALCIUM/CALMODULIN-DEPENDENT PROTEIN-KINASE-II DOWN-REGULATES BOTH CALCINEURIN AND PROTEIN-KINASE C-MEDIATED PATHWAYS FOR CYTOKINE GENE-TRANSCRIPTION IN HUMAN T-CELLS [J].
HAMA, N ;
PALIOGIANNI, F ;
FESSLER, BJ ;
BOUMPAS, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1217-1222